QuintilesIMS Real-World Insights Bibliography

A Retrospective Study of Ranibizumab Treatment Regimens for Neovascular Age-Related Macular Degeneration (nAMD) in Australia and the United Kingdom.
Author(s): Johnston RL1,2, Carius HJ3, Skelly A4, Ferreira A5, Milnes F4, Mitchell P6.
Affiliations(s): 1 The Royal College of Ophthalmologists' National Ophthalmology Database, London, UK. 2 Gloucestershire Hospitals NHS Foundation Trust, Cheltenham, UK. 3 QuintilesIMS, Frankfurt am Main, Germany. 4 Novartis Pharma AG, Basel, Switzerland. 5 Novartis Pharma AG, Basel, Switzerland. alberto.ferreira@novartis.com. 6 Department of Ophthalmology, Westmead Millennium Institute, University of Sydney, Westmead, NSW, Australia.
Publication(s): Advances in therapy
Document Type(s): Article
Countries: Australia, UK
Click here for the abstract
C:
Y:
Ophthalmology
2017
  L:
A:
English
Retrospective cohort analysis
  Add to report
 
 
Multicenter evaluation of Time, Operational and Economic Efficiencies of a New Pre-loaded IOL delivery system vs manual IOL delivery
Author(s): Mendicute J1, Pablo L2, Vélasque L3, Martinez A4, Asmar J5, Schweitzer C6
Affiliations(s): 1.Hospital Universitario Donostia Servicio de Oftalmología 2.Hospital Universitario Miguel Servet Servicio de Oftalmología 3.Centre Retine Gallien Bordeaux 4.Alcon Laboratories, Inc., Fort Worth, TX 5.IMS Health Information Solutions France 6.Department of Ophthalmology, Bordeaux University Hospital, France
Publication(s): ASCRS (cataract congress)
Document Type(s): Abstract, Poster
Countries: France
C:
Y:
Ophthalmology
2017
  L:
A:
English
Cost effectiveness, Observational study, Prospective study
  Add to report
 
 
RiGOR: a prospective observational study comparing the effectiveness of treatment strategies for open-angle glaucoma
Author(s): Coleman AL, Lum FL, Velentgas P, Campion D, Su Z, Gliklich RE
Affiliations(s): 
Publication(s): Journal of Comparative Effectiveness. Jan 2016; 5(1), 65-78 ISSN 2042-6305
Document Type(s): Article
Countries: 
C:
Y:
Ophthalmology
2016
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Practice patterns and treatment changes for open-angle glaucoma: the RiGOR study
Author(s): Coleman AL, Lum FL, Velentgas P, Su Z, Gliklich RE
Affiliations(s): 
Publication(s): J Comparative Effectiveness. Jan 2016; 5(1), 79-85 ISSN 2042-6305
Document Type(s): Article
Countries: 
C:
Y:
Ophthalmology
2016
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Impact of treatment strategies for open angle glaucoma on intraocular pressure: the RiGOR study
Author(s): Coleman AL, Lum FL, Velentgas P, Su Z, Gliklich RE
Affiliations(s): 
Publication(s): J Comparative Effectiveness. Jan 2016; 5(1), 87–98 ISSN 2042-6305
Document Type(s): Article
Countries: 
C:
Y:
Ophthalmology
2016
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Quality of life and visual acuity outcomes in the RiGOR study
Author(s): Coleman AL, Lum FL, Gliklich RE, Velentgas P, Su Z
Affiliations(s): 
Publication(s): J Comparative Effectiveness. Jan 2016; 5(1), 99-111 ISSN 2042-6305
Document Type(s): Article
Countries: 
C:
Y:
Ophthalmology
2016
  L:
A:
English
RWLPR (Real-World Late Phase Research-quintiles
  Add to report
 
 
Cost-effectiveness analysis of ex-vivo expanded autologous human corneal epithelial cells containing stem cells to repair the damaged ocular surface in patients with moderate to severe limbal stem cell deficiency due to ocular burns in the UK
Author(s): Fordham R1, Ciminata G1, Madoni A2, Magni T2, Ardigò D2, Pelosi D2, Withe M2, Sarnelli V3, Deltetto I3, Domini B3
Affiliations(s): 1 University of East Anglia, Norwich, UK and IMS Health, London, UK 2 Chiesi Farmaceutici Spa, Parma, Italy 3 Ernst & Young, Milano, Italy
Publication(s): ISPOR 20th Annual International Meeting, 16th - 20th May 2015, Philadelphia, PA, USA
Document Type(s): Poster
Countries: UK
C:
Y:
Ophthalmology
2015
  L:
A:
English
Cost effectiveness
  Add to report
 
 
Diabetes, Cardiovascular Morbidity, and Risk of Age-Related Macular Degeneration in a Primary Care Population
Author(s): Vassilev ZP, Ruigómez A, Soriano-Gabarró M, García Rodríguez LA
Affiliations(s): Bayer Pharma; Spanish Centre for Pharmacoepidemiologic Research (CEIFE)
Publication(s): 
Document Type(s): Article
Countries: UK
C:
Y:
Cardiovascular disease, Diabetes, Miscellaneous, Ophthalmology
2015
  L:
A:
English
Retrospective database analysis
  Add to report
 
 
Improvement in glaucoma patient quality of life by therapy switch to preservative-free timolol/dorzolamide fixed combination.
Author(s): Abegão Pinto L1,4, Vandewalle E1, Gerlier L3, Stalmans I1,2
Affiliations(s): 1 Department of Ophthalmology, University Hospitals Leuven, Leuven, Belgium 2 Department of Ophthalmology Neurosciences, Laboratory of Ophthalmology, KU Leuven, Leuven, Belgium 3 IMS Health, Vilvoorde, Belgium 4 Department of Pharmacology and Neurosciences, Faculty of Medicine of Lisbon University, Lisbon, Portugal
Publication(s): Ophthalmologica. 2014, 231(3): 166-171. doi: 10.1159/000356468. Epub 2013 Dec 21.
Document Type(s): Article
Countries: 
Click here for the abstract
C:
Y:
Ophthalmology
2014
  L:
A:
English
Prospective study, Quality of life
  Add to report
 
 
Treatment discontinuation in patients with urinary incontinence suffering from glaucoma
Author(s): Kostev K1, Rex J1, Engelhard J1, Altmann V1, Ehlken B2, Rockel T1, Kalder M3
Affiliations(s): 1IMS Health, Frankfurt am Main, Germany, 2IMS Health Germany, Munich, Germany, 3University Hospital of Gießen and Marburg, Marburg, Germany
Publication(s): ISPOR 17th Annual European Congress, 8-12 November 2014, Amsterdam, The Netherlands
Document Type(s): Poster
Countries: 
C:
Y:
Ophthalmology
2014
  L:
A:
English
Compliance
  Add to report
 
 
 1 of 6 Next Page Last Page